4 ms·
Similar to Pear Therapeutics that SPAC merge announced at $1.6B on about $500k revenue 12 months to date. Professional Analysts put stock target at twice first
by throwawaypppu 4y ago
Similar to Pear Therapeutics that SPAC merge announced at $1.6B on about $500k revenue 12 months to date. Professional Analysts put stock target at twice first listing price. Had been around 10 years. Products in market for years. Market cap now $235M.Trading at or below cash.
- prewett 4y agoWow, that reminds me of Agillion, a dot-bomb which got $40 million of VC investment and $20 million in loans and had "hundreds of dollars" in sales. Plus $200k the founder(s) paid for the code in the bankruptcy. [1] https://www.dcpartners.solutions/2022/02/agillion-what-was-it-and-about-its-failure/ https://www.dcpartners.solutions/2022/02/agillion-what-was-i...